Search results for

Our 50 favorite songs from the first half of the year offer many different pleasures and got stuck in our heads for different reasons, but they all managed to become essential.

President Obama visits Mexico this week and some of the usual issues are no longer at the top of the agenda. Host Michel Martin talks with Alfredo Corchado, Mexico bureau chief for The Dallas Morning News, who calls the trip a huge shift in U.S.-Mexico relations.

The partially collapsed condo in Surfside has been demolished. The Taliban advance across Afghanistan as U.S. forces leave the country. A look inside the conference for top media and tech moguls.

What exactly is happening to nurses' backs when they move and lift patients? NPR's Daniel Zwerdling teamed with scientists for a high-tech look inside his own back as he tried the same maneuvers.

The Taliban still have no formal government in Afghanistan. Days after Hurricane Ida, rescue teams have difficulty reaching people. Texas Republicans pass a new bill restricting voting rights.

The Labor Department reports consumer prices data. The White House hosts a virtual global summit to discuss ransomware. The FDA allows a brand of e-cigarettes to stay on the market.

NPR's Mary Louise Kelly speaks with commanding general of the Afghan Army, Gen. Sami Sadat, about U.S. troops being almost completely withdrawn from Afghanistan.

NPR's Ari Shapiro talks with New York Times writer Jazmine Hughes about the unique pop stardom Lil Nas X is creating for himself.

Russia says it's de-escalating its forces near Ukraine. Florida's House passes a bill banning abortions after 15 weeks of pregnancy. The DOJ is suing Missouri over its controversial firearm law.

Merck documents show that in 2000, the maker of Vioxx tried to censor critics of the drug's safety. That was the year that drug giant Merck learned that Vioxx might cause heart attacks and other problems. The documents show a concerted effort by the company to identify doctors who were raising questions about the drug's safety and to put pressure on them to stop making critical comments. A spokesman for Merck denies the allegations.